Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Stem Cell Reviews and Reports
|
March 4, 2019
Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
Gina Ma, Jiaqi Shen, Kevin Pinz, et al.
Stem Cell Reviews and Reports
|
August 30, 2021
Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR
Wenli Zhang, Jia Feng, Andrew Cinquina, et al.
Stem Cell Reviews and Reports
|
June 23, 2025
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
Min Wang, Vincent M DeStefano, Ling Ding, et al.
Journal of Hematology & Oncology
|
January 30, 2026
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
Ming Hong, Mingxia Wang, Ronghao Zeng, et al.
Annals of the Rheumatic Diseases
|
May 22, 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang, Shanzhi He, Wenli Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Stem Cell Reviews and Reports
|
March 4, 2019
Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
Gina Ma, Jiaqi Shen, Kevin Pinz, et al.
Stem Cell Reviews and Reports
|
August 30, 2021
Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR
Wenli Zhang, Jia Feng, Andrew Cinquina, et al.
Stem Cell Reviews and Reports
|
June 23, 2025
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
Min Wang, Vincent M DeStefano, Ling Ding, et al.
Journal of Hematology & Oncology
|
January 30, 2026
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial
Ming Hong, Mingxia Wang, Ronghao Zeng, et al.
Annals of the Rheumatic Diseases
|
May 22, 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang, Shanzhi He, Wenli Zhang, et al.
Page
of 1